Actionable news
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Today's Perilous Reversal Stock: Sarepta Therapeutics (SRPT)

Trade-Ideas LLC identified Sarepta Therapeutics ( SRPT) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Sarepta Therapeutics as such a stock due to the following factors:

  • SRPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $58.2 million.
  • SRPT has traded 1.6 million shares today.
  • SRPT is down 3.1% today.
  • SRPT was up 19.3% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in SRPT with the Ticky from Trade-Ideas. See the FREE profile for SRPT NOW at Trade-Ideas More details on SRPT: Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Currently there are 5 analysts that rate Sarepta Therapeutics a buy, 1 analyst rates it a sell, and 6 rate it a hold. The average volume for Sarepta Therapeutics has been 2.3 million shares per day over the past 30 days. Sarepta has a market cap of $891.9 million and is part of the health care sector and drugs industry. The...